Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence

In 2014, the Food and Drug Administration approved a new human papillomavirus 9-valent vaccine (9vHPV), targeting nine HPV types: HPV types 6, 11, 16, and 18, which are also targeted by the quadrivalent HPV vaccine (qHPV), plus five additional high cancer risk HPV types (HPV types 31, 33, 45, 52, an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Epidemiol Infect
Prif Awduron: SIGNORELLI, C., ODONE, A., CIORBA, V., CELLA, P., AUDISIO, R. A., LOMBARDI, A., MARIANI, L., MENNINI, F. S., PECORELLI, S., REZZA, G., ZUCCOTTI, G.V., PERACINO, A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Cambridge University Press 2017
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5974698/
https://ncbi.nlm.nih.gov/pubmed/28446260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0950268817000747
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg